Anika Announces FDA 510(k) Clearance for its WristMotion Total Arthroplasty System

Anika Therapeutics was granted FDA 510(k) clearance to market the WristMotion® Total Arthroplasty System.

The regulatory milestone triggers a one-time $5 million earnout payment as set forth in the company's acquisition of Arthrosurface earlier this year. The earnout payment will be paid in 4Q20.

WristMotion modular joint...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us